Florian Naudetil y a 1 jour4 MinFeedback on the process of our first registered report"Registered Reports is a publishing format that emphasizes the importance of the research question and the quality of methodology by...
Florian Naudetil y a 4 jours3 MinData-sharing and re-analysis for main studies assessed by the EMA: our first registered report!We have just published our first registered report in BMC Medicine. Let's celebrate ! Transparency and reproducibility are expected to be...
Florian Naudet15 nov. 20211 MinRegistered report / in principle acceptance: esketamine for “treatment resistant depression"Our new registered report "Efficacy and safety of esketamine for “treatment resistant depression”: registered report for a Systematic...
Florian Naudet22 août 20212 MinStudying the impact of data sharing initiativesIn our new scoping review, we explored the impact of clinical trial data-sharing initiatives. We looked at various outcome domains...
Florian Naudet9 août 20212 MinAn open science pathway for drug marketing authorizationOur essay "An open science pathway for drug marketing authorization -Registered drug approval" won the "Reimagine Biomedical Research for...
Florian Naudet25 mai 20213 MinConcerns about the Sputnik V phase 3 trialIn a recent letter, as part of an international group (Enrico Bucci, Johannes Berkhof, André Gillibert, Gowri Gopalakrishna, Raffaele A...
Florian Naudet30 avr. 20211 MinSharing of Clinical Trial Data - 2nd Workshop - RecordingsOn April 1st, 2021, our group and colleagues from the Ludwig-Maximilians-Universität München (Faculty of Medicine) organized a workshop...
Florian Naudet27 mars 20215 MinConflicts of interests in researchWe have just registered our new protocol on the Open Science Framework. We are planning a new study about conflict of interests in...
Florian Naudet24 mars 20212 MinSharing of Clinical Trial Data - 2nd Workshop 1.04.2021Again some good news! On April the 1st this year, our group and colleagues from the Ludwig-Maximilians-Universität München (Faculty of...
Florian Naudet7 janv. 20211 MinSharing of Clinical Trial Data - Workshop 19.01.2021Finally some good news in 2021 ! On January 19th this year, our group and colleagues from the Ludwig-Maximilians-Universität München...
fabiola gaba20 août 20201 MinFunders' data sharing policies in therapeutic research“Funders’ data-sharing policies in therapeutic research: a survey of commercial and non-commercial funders” is the new article, from the...
Florian Naudet7 août 20203 MinArtemisia infusions: correcting the records was difficultThis story is about Artemisia and two very "interesting" (or should I say infamous) studies. 1/ Well, read this paper: "Artemisia annua...
Florian Naudet25 juin 202014 MinProposal for improved reporting of the RECOVERY trial Taking advantage of the many good things pre print servers offer, and in a spirit of open science, we wrote a peer review with Andre...
Max31 mai 20201 MinAn Audit of journals following the ICMJE recommendations"Data-sharing recommendations in biomedical journals and Randomized Controlled Trials: an audit of journals following the ICMJE...
Florian Naudet5 mai 20204 MinThe BACLOVILLE study and the long road to transparencyWe hypothesize in our projects that re-analyses of a random sample of unselected Randomised Controlled Trials will result in a good...
Max10 avr. 20202 Min ReiTheR goes BerlinIn mid-february our team made its way to the 3 day REWARD EQUATOR conference, which was hosted by the BIH Quest Center in Berlin,...
Florian Naudet8 avr. 20201 MinEMA monitorOur new paper, "The evidence base for psychotropic drugs approved by the European Medicines Agency [EMA]: a meta-assessment of all...
Florian Naudet6 avr. 20201 MinOur blogReproducibility in Therapeutic Research (ReITheR) is a research program funded by the French Agence Nationale de la Recherche. The team...